[{"id":"59c4433e-178c-41e8-bb65-1d9a0a1d95a4","acronym":"","url":"https://clinicaltrials.gov/study/NCT05631899","created_at":"2022-11-30T17:57:34.718Z","updated_at":"2024-07-02T16:35:20.773Z","phase":"Phase 1","brief_title":"CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT05631899","lead_sponsor":"Chinese PLA General Hospital","biomarkers":" KRAS","pipe":" | ","alterations":" PD-L1 expression • KRAS mutation • MSI-H/dMMR • KRAS G12C • KRAS G12D • KRAS G12V • KRAS G12","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • KRAS mutation • MSI-H/dMMR • KRAS G12C • KRAS G12D • KRAS G12V • KRAS G12"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Yervoy (ipilimumab) • albumin-bound paclitaxel • cyclophosphamide • KRAS-EphA-2-CAR-DC"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 04/03/2023","start_date":" 04/03/2023","primary_txt":" Primary completion: 12/30/2025","primary_completion_date":" 12/30/2025","study_txt":" Completion: 12/30/2026","study_completion_date":" 12/30/2026","last_update_posted":"2024-02-06"}]